PACB stock jumps as HiFi whole-genome sequencing becomes first-line in major SUDC research, highlighting adoption momentum.

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration directive to cut the cost of medical research grants, major makers of DNA ...

There have been five primary stages in the genomic-sequencing pioneer's history. Here's what has happened with Illumina stock history so far. The first years for Illumina weren't too fun for ...

An updated edition of the June 27, 2025, article. Genomics encompasses the study of a complete set of genes, their work process and way of interacting with each other and the environment. There have ...

Myriad Genetics, Inc. MYGN is well-poised to grow in the coming quarters due to its impressive cadence of product launches. The company is also progressing well in its refreshed long-term strategy to ...

Regeneron collaborates with Truveta to expand a genomic database, investing $119.5 million to enhance genetics-based healthcare research. Regeneron's $119.5 million investment in Truveta's Series C ...

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...